Literature DB >> 16481740

Increased gene copy number of the transcription factor E2F1 in malignant melanoma.

Mark A Nelson1, Steven H Reynolds, Uma N M Rao, Anne-Christine Goulet, Yongmei Feng, Anthony Beas, Barbara Honchak, Jim Averill, David T Lowry, Jamie R Senft, Amy M Jefferson, Robert C Johnson, Linda M Sargent.   

Abstract

Translocations and unique chromosome break points in melanoma will aid in the identification of the genes that are important in the neoplastic process. We have previously shown a unique translocation in malignant melanoma cells der(12)t(12;20). The transcription factor E2F1 maps to 20q11. Increased expression of E2F has been associated with the autonomous growth of melanoma cells, however, the molecular basis has not yet been elucidated. To this end, we investigated E2F1 gene copy number and structure in human melanoma cell lines and metastatic melanoma cases. Fluorescent in situ hybridization (FISH) analysis using a specific E2F1 probe indicated increased E2F1 gene copies in melanoma cell lines compared to normal melanocytes. We also observed increased copies of the E2F1 gene in lymph node metastases of melanoma. In addition, Western blot analysis demonstrated increased E2F1 protein levels in 8 out of 9 melanoma cell lines relative to normal melanocytes. Inhibition of E2F1 expression with RNAi also reduced melanoma cell growth. Our results suggest that the release of E2F activity by elevated E2F1 gene copy numbers may play a functional role in melanoma growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16481740     DOI: 10.4161/cbt.5.4.2512

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  21 in total

Review 1.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

2.  miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.

Authors:  Altaf A Dar; Shahana Majid; David de Semir; Mehdi Nosrati; Vladimir Bezrookove; Mohammed Kashani-Sabet
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

3.  Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.

Authors:  Carolina J Jorgez; Nathan Wilken; Josephine B Addai; Justin Newberg; Hima V Vangapandu; Alexander W Pastuszak; Sarmistha Mukherjee; Jill A Rosenfeld; Larry I Lipshultz; Dolores J Lamb
Journal:  Fertil Steril       Date:  2014-10-24       Impact factor: 7.329

4.  Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Authors:  Xiaoqi Xie; John E Kerrigan; Tamara Minko; Olga Garbuzenko; Kuo-Chieh Lee; Alex Scarborough; Emine Ercikan Abali; Tulin Budak-Alpdogan; Nadine Johnson-Farley; Debabrata Banerjee; Kathleen W Scotto; Joseph R Bertino
Journal:  Cancer Biol Ther       Date:  2013-06-03       Impact factor: 4.742

5.  Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.

Authors:  Sandeep Singh; Rebecca Davis; Vignesh Alamanda; Roberta Pireddu; Daniel Pernazza; Said Sebti; Nicholas Lawrence; Srikumar Chellappan
Journal:  Mol Cancer Ther       Date:  2010-12-07       Impact factor: 6.261

Review 6.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

7.  ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Authors:  Linan Ha; Takeshi Ichikawa; Miriam Anver; Ross Dickins; Scott Lowe; Norman E Sharpless; Paul Krimpenfort; Ronald A Depinho; Dorothy C Bennett; Elena V Sviderskaya; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 8.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

9.  AP-2α-Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis.

Authors:  Jeffrey R White; Dakota T Thompson; Kelsey E Koch; Boris S Kiriazov; Anna C Beck; Dana M van der Heide; Benjamin G Grimm; Mikhail V Kulak; Ronald J Weigel
Journal:  Cancer Res       Date:  2021-07-01       Impact factor: 12.701

10.  E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women.

Authors:  Maria Santa Rocca; Clara Benna; Elena Goldin; Andrea Di Nisio; Luca De Toni; Ilaria Cosci; Alberto Marchet; Donato Nitti; Carlo Foresta
Journal:  Mol Med       Date:  2021-03-10       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.